Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹2,835.10
Market cap: ₹21,550 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 32.4×Sector 50.4×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Price Movement Clarification 2 Financial Results 2 Annual General Meeting 2 Other Announcement 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Sep 2026 18:45 IST NSE

Price Movement Clarification

Caplin Point Laboratories Price Movement Clarification

Caplin Point Laboratories clarified that the recent increase in its stock's trading volume is market-driven. The company confirmed no undisclosed material information exists regarding this movement.

Read the filing ↗

2 Sep 2026 17:29 IST NSE

Price Movement Clarification

Caplin Point Laboratories Price Movement Clarification

Caplin Point Laboratories has clarified that recent trading volume spikes are market-driven. The company confirms it has no undisclosed price-sensitive information.

Read the filing ↗